Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06366451
Status:
RECRUITING
Last Update Posted:
2024-06-07
First Post:
2024-04-03
Brief Title:
PBI-MST-01 NCT04541108 Substudy AZN-05 Intratumoral Microdosing of Rilvegostomig Volrustomig and Sabestomig in HNSCC
Sponsor:
Presage Biosciences
Organization:
Presage Biosciences
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Squamous Cell Carcinoma |
Keywords:
| Name | View |
|---|---|
| spatial biology | View |
| HNSCC | View |
| intratumoral microdosing | View |
| microdose injection | View |
| microdosing | View |
| in vivo oncology | View |
| tumor microenvironment | View |
| multiplexed immunohistochemistry | View |
| head and neck cancer | View |
| head and neck squamous cell carcinoma | View |
| pharmacodynamic biomarkers | View |
| CIVO | View |
| master protocol | View |
| precision oncology | View |